// App-Quantinova.ai

6072 : Clinical disease course and survival outcomes following disease recurrence in adenoid cystic carcinoma (ACC) with NOTCH signaling pathway activation.

Researchers

Presenter

  • Brindley Sonal Hapuarachi

Principal Investigators

  • Laura Feeney

  • Sam Rack

  • Helen Adderley

  • David Morgan

  • Guy Betts

  • Russell Walker

  • Rami Rauch

  • Elad Herz

  • Kevin Joseph Harrington

  • Robert Metcalf

Medical Centers

  • The Royal Hallamshire Hospital, Sheffield Teaching Hospitals, NHS Foundation Trust, Sheffield, United Kingdom

  • Belfast City Hospital, Belfast, United Kingdom

  • The Christie NHS Foundation TRUST, Manchester, United Kingdom

  • University of Manchester, Manchester, United Kingdom

  • Ayala Pharmaceuticals, Inc., Wilmington, MD, Ayala Pharmaceuticals, Wilmington, DE, Ayala Pharmaceuticals, Inc., Wilmington, DE, The Royal Marsden//The Institute of Cancer Research NIHR Biomedical Research Centre, London, United Kingdom

  • The Christie NHS Foundation TRUST, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Adenoid cystic carcinoma

  • Solid malignancies

Biomarkers

  • Acetyl-CoA carboxylase

  • Neurogenic locus notch homolog protein 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved